Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Life (Basel, Switzerland)|March 29, 2023
Comparative Treatment Study on Macular Edema Secondary to Branch Retinal Vein Occlusion by Intravitreal Ranibizumab with and without Selective Retina TherapyManabu Yamamoto, Yoko Miura, Kumiko Hirayama, et al.
International Ophthalmology|January 18, 2020
Predictive factors of outcome of selective retina therapy for diabetic macular edemaManabu Yamamoto, Yoko Miura, Kumiko Hirayama, et al.
Plos One|March 31, 2022
FOXP3 and CXCR4-positive regulatory T cells in the tumor stroma as indicators of tumor immunity in the conjunctival squamous cell carcinoma microenvironmentMizuki Tagami, Anna Kakehashi, Atsuko Katsuyama-Yoshikawa, et al.
Japanese Journal of Ophthalmology|April 11, 2023
Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 1-year results from the Japan subgroup of the phase 3 TENAYA trialRyusaburo Mori, Shigeru Honda, Fumi Gomi, et al.
Scientific Reports|April 27, 2021
Factors affecting resolution of subretinal fluid after selective retina therapy for central serous chorioretinopathyAkika Kyo, Manabu Yamamoto, Kumiko Hirayama, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 14, 2024
Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trialHideki Koizumi, Fumi Gomi, Akitaka Tsujikawa, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 3, 2024
Artificial intelligence-based differential diagnosis of orbital MALT lymphoma and IgG4 related ophthalmic disease using hematoxylin-eosin imagesMizuki Tagami, Mizuho Nishio, Atsuko Yoshikawa, et al.
Plos One|May 26, 2026
Development and evaluation of AI model with deep learning for segmentation of extraocular muscles in thyroid eye diseaseYusuke Haruna, Mizuki Tagami, Ryo Kurosaki, et al.
Ophthalmology and Therapy|October 15, 2020
One-Year Results of a Treat-and-Extend Regimen of Intravitreal Aflibercept for Polypoidal Choroidal VasculopathyTomoko Tamachi, Takeya Kohno, Manabu Yamamoto, et al.
The British Journal of Ophthalmology|August 6, 2018
Long-term results of photodynamic therapy or ranibizumab for polypoidal choroidal vasculopathy in LAPTOP studyNoriko Miyamoto, Michiko Mandai, Akio Oishi, et al.
Pageof 15